Compare SXC & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SXC | BVS |
|---|---|---|
| Founded | 1960 | 2011 |
| Country | United States | United States |
| Employees | 848 | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 756.9M | 783.2M |
| IPO Year | 2011 | 2016 |
| Metric | SXC | BVS |
|---|---|---|
| Price | $8.28 | $13.64 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $9.00 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 1.5M | 699.1K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 7.17% | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | ★ 0.10 | 0.04 |
| Revenue | ★ $1,600,300,000.00 | $568,087,000.00 |
| Revenue This Year | N/A | $7.52 |
| Revenue Next Year | N/A | $7.06 |
| P/E Ratio | ★ $89.50 | $329.25 |
| Revenue Growth | ★ 10.30 | N/A |
| 52 Week Low | $5.52 | $5.81 |
| 52 Week High | $9.74 | $13.55 |
| Indicator | SXC | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 43.80 | 71.86 |
| Support Level | $7.69 | $8.04 |
| Resistance Level | $8.38 | N/A |
| Average True Range (ATR) | 0.49 | 0.55 |
| MACD | -0.02 | 0.09 |
| Stochastic Oscillator | 35.87 | 88.30 |
SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is mainly used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through two segments: Domestic Coke and Industrial Services. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal-producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.